Combined oral contraceptives in improving quality of young women’s lives

2019 ◽  
Vol 1 (1) ◽  
pp. 15-18
Author(s):  
A. L. Tikhomirov ◽  
T. A. Yudina ◽  
D. I. Burchakov
Keyword(s):  
Side Effects ◽  
Oral Contraceptives ◽  
Hormonal Contraception ◽  
Hormonal Contraceptive ◽  
Combined Oral Contraceptives ◽  
Distinctive Features ◽  
Women's Lives ◽  
Combined Hormonal Contraceptive

Compliance with the use of combined hormonal contraceptive drugs containing drospirenone is presented. The use of such drugs enhances the use of hormonal contraception. The distinctive features of the drugs are considered: reliable contraception, reduced severity of side effects, additional positive preventive and curative effects.

Folate contraception and clinical practice

GYNECOLOGY ◽  
2020 ◽  
Vol 22 (6) ◽  
pp. 101-107
Author(s):  
Vera N. Prilepskaya ◽  
Lana L. Bostandzhian
Keyword(s):  
Oral Contraceptives ◽  
Hormonal Contraception ◽  
The Body ◽  
Reproductive Age ◽  
Folate Supplementation ◽  
Combined Oral Contraceptives ◽  
Dosage Regimens ◽  
Gynecological Diseases ◽  
Unwanted Pregnancies ◽  
Fetal Malformations

Since the first pill, there has been a significant evolution of hormonal contraception: low- and micro-dose drugs have appeared, drugs with components as close as possible to endogenous hormones have been developed, new dosage regimens and routes of contraceptive administration have been created. Modern combined oral contraceptives are not only used to prevent unwanted pregnancies, but are also widely used to treat a number of gynecological and non-gynecological diseases. In recent years, two new combined oral contraceptives with folate supplementation have been developed. The main purpose of adding folate to contraceptives is the prevention of fetal malformations, which is ensured by an increase in the level of folate in the body of women of reproductive age against the background of contraception and after its withdrawal.

scholarly journals POSSIBILITIES OF ULTRASONIC MONITORING OF ENDOMETRIUM AND OVARIES IN PATIENTS AFTER CANCELLATION OF LONG-TERM RECEPTION OF COMBINED ORAL CONTRACEPTIVES WHEN PLANNING PREGNANCY

2019 ◽  
Vol 6 (4) ◽  
pp. 215-220
Author(s):  
Sh. N Bortsvadze ◽  
Evgeniya A. Svidinskaya ◽  
T. A Dzhibladze ◽  
I. D Khokhlova ◽  
Yan Van
Keyword(s):  
Menstrual Cycle ◽  
Oral Contraceptives ◽  
Ovarian Tissue ◽  
Hormonal Contraception ◽  
Reproductive Function ◽  
Good Health ◽  
Automatic Assessment ◽  
Normal Limits ◽  
Ultrasound Diagnostics

The article aims to assess the possibility of ultrasound scanning and dopplerstudy in the assessment of the condition of the ovaries and endometrial in patients after long intake of COC, predicting the restoration of reproductive function after the abolition of hormonal contraception. Material and methods. In 2018-2019, 37 women were examined after the abolition of oral contraceptives, which they took for a long period of time. At the time of the examination, all the patients stopped taking COC at least 2 months ago due to the fact that they were planning a pregnancy. UW the study was conducted on the apparat Voluson E8 Expert (General Electric), improving the quality of diagnostics used Automatic assessment of follicle condition based on ultrasonic echography (Sono AVCTM follicle) and tomographic ultrasound (TUI). Results. According to the study significant changes recorded 17 patients whose menstrual cycle did not recover within the first 6 months after the cancellation of COC. In a group of 20 patients with a regular menstrual cycle, the results of the study were within normal limits, pregnancy within 6 months occurred on their own in 8 of them. Conclusion. The possibilities of 3 dimensional reconstruction and programs for evaluating the follicular apparatus significantly improve the quality of ultrasound diagnostics, give more information about the presence of small follicles, blood flow in the ovarian tissue, the structure of the cortical apparatus substances and stroma, whichis the ability of a clinician to obtain a complete understanding of the condition of the ovaries and endometrial and predicting a good health of patients. The article may be of interest to obstetricians-gynecologists, ultrasound specialists, endocrinologists, reproductive specialists.

Effect of oral contraceptives on the production and composition of human milk

1977 ◽  
Vol 9 (S4) ◽  
pp. 123-133 ◽  
Author(s):  
A. N. Gupta ◽  
V. S. Mathur ◽  
S. K. Garg
Keyword(s):  
Side Effects ◽  
Human Milk ◽  
Oral Contraceptives ◽  
Low Dose ◽  
Lactating Women ◽  
Endocrine Profile ◽  
Quality Of Milk ◽  
Drop Outs ◽  
Selection Of

SummaryOne hundred and thirty six lactating women were studied, 42 controls and 94 taking oral contraceptives. Combination pills of oestrogen and progestogen (Primovlar and Minovlar) and a low dose progestogen pill (Norgestrel) were used. The selection of a particular formulation was based on the endocrine profile of an individual; this reduced drop-outs due to side effects.The change in the quantity of milk was assessed by test-feeding followed by manual expression. Milk was also analysed quantitatively. Significant reduction in the milk yield was found with the Primovlar and Minovlar groups but no change was observed with Norgestrel. No change in the quality of milk was found for any of the three groups.

scholarly journals Hormonal contraception and HIV acquisition among women: an updated systematic review

2020 ◽  
Vol 46 (1) ◽  
pp. 8-16 ◽  
Author(s):  
Kathryn M Curtis ◽  
Philip C Hannaford ◽  
Maria Isabel Rodriguez ◽  
Tsungai Chipato ◽  
Petrus S Steyn ◽  
...  
Keyword(s):  
Systematic Review ◽  
Observational Study ◽  
Oral Contraceptives ◽  
Hiv Risk ◽  
Contraceptive Method ◽  
Hormonal Contraception ◽  
Hormonal Contraceptive ◽  
Contraception Use ◽  
Hiv Acquisition ◽  
Risk Of Hiv Acquisition

ObjectiveTo update a 2016 systematic review on hormonal contraception use and HIV acquisition.MethodsWe searched Pubmed and Embase between 15 January 2016 and 26 June 2019 for longitudinal studies comparing incident HIV infection among women using a hormonal contraceptive method and either non-users or users of another specific hormonal contraceptive method. We extracted information from newly identified studies, assessed study quality, and updated forest plots and meta-analyses.ResultsIn addition to 31 previously included studies, five more were identified; three provided higher quality evidence. A randomised clinical trial (RCT) found no statistically significant differences in HIV risk among users of intramuscular depot medroxyprogesterone acetate (DMPA-IM), levonorgestrel implant (LNG implant) or the copper intrauterine device (Cu-IUD). An observational study found no statistically significant differences in HIV risk among women using DMPA, norethisterone enanthate (NET-EN), implants (type not specified) or Cu-IUD. Updated results from a previously included observational study continued to find a statistically significant increased HIV risk with oral contraceptives and DMPA compared with no contraceptive use, and found no association between LNG implant and HIV risk.ConclusionsHigh-quality RCT data comparing use of DMPA, LNG implant and Cu-IUD does not support previous concerns from observational studies that DMPA-IM use increases the risk of HIV acquisition. Use of other hormonal contraceptive methods (oral contraceptives, NET-EN and implants) is not associated with an increased risk of HIV acquisition.

Recent Advances in Hormonal Contraceptives for Women

2008 ◽  
Vol 1 (3) ◽  
pp. 199-206
Author(s):  
D. Samba Reddy
Keyword(s):  
Birth Control ◽  
Oral Contraceptives ◽  
Hormonal Contraception ◽  
Daily Intake ◽  
Hormonal Contraceptive ◽  
Hormonal Contraceptives ◽  
Breakthrough Bleeding ◽  
Contraceptive Agents ◽  
Recent Advances ◽  
Hormone Injection

Currently, Contraceptive agents play a key role in family planning in India. Hormonal contraception is the marketed most common birth control option in women. An estimated 100 million women throughout the world use hormonal contraceptives for prevention of pregnancy. This article briefly describes the recent advances in hormonal contraceptive strategies that may minimize side effects while optimizing effective contraception. There are four types of hormonal contraceptive agents available for birth control. They include oral contraceptives pills (combined and mini-pills), contraceptive patches, hormonal implants, intrauterine devices and hormone injection agents. Oral contraceptives (OCs) are among the most widely used agents because they are highly effective when used properly. Generally, OCs are designed to simulate the 28 days of the menstrual cycle by daily intake of steroid hormones consisting of an estrogen and/or a progesterone. The primary mechanism underlying OC action is inhibition of ovulation. This action is achieved using a variety of OCs with substantially different components, doses, and side effect profile.  Two types of OC pills are widely available: combination pills; and progesterone only pills. The combined daily OC pill is composed of low dose of synthetic estrogen and progesterone. They are usually taken for 21 days with a 7 day gap during which menstruation-like bleeding occurs. Recently, there are several new OCs that have been approved to minimize the frequency and/or extent of breakthrough bleeding while achieving reliable means of contraception for the avoidance of unplanned pregnancies.

Opportunities of treatment for primary dysmenorrhea in young women. Case report

GYNECOLOGY ◽  
2021 ◽  
Vol 23 (3) ◽  
Author(s):  
Nataliya A. Buralkina ◽  
Zalina K. Batyrova ◽  
Zaira K. Kumykova
Keyword(s):  
Quality Of Life ◽  
Oral Contraceptives ◽  
Young Women ◽  
Pain Syndrome ◽  
Primary Dysmenorrhea ◽  
Combined Oral Contraceptives ◽  
Common Causes ◽  
Effective Use ◽  
Safe Treatment Option

Primary dysmenorrhea is one of the most common causes of pelvic pain in women. It can reduce quality of life and interfere with daily activities. The use of combined oral contraceptives in young women with primary dysmenorrhea is an effective and safe treatment option. The article presents a clinical case of the effective use of combined oral contraceptives containing drospirenone in a young woman with primary dysmenorrhea and severe pain syndrome, which is not relieved by analgesics and antispasmodics and significantly reduces the patient's quality of life.

The Critical Oestrogen Content of Combined Oral Contraceptives

1975 ◽  
Vol 3 (6) ◽  
pp. 407-412 ◽  
Author(s):  
J P Mumford
Keyword(s):  
Side Effects ◽  
Oral Contraceptives ◽  
Patient Acceptance ◽  
Similar Reduction ◽  
Combined Oral Contraceptives ◽  
Critical Dose ◽  
Irregular Bleeding

A review of the evidence concerning efficacy, safety and side-effects of oral contraceptives indicates clear differences related to the lowering of oestrogen dosage. It is suggested that 50 μ g of ethinyloestradiol or its equivalent is a critical dose, for below that level the efficacy in combination with current progestogens falls almost twenty-fold without evidence of a similar reduction in unwanted side-effects. In fact there is a marked increase of irregular bleeding patterns in early cycles associated with diminished patient acceptance.

scholarly journals How to reduce the number of side effects produced by COCs and improve adherence: simple tips for practitioners

2016 ◽  
pp. 10-13
Author(s):  
G. B. Dikke
Keyword(s):  
Side Effects ◽  
Oral Contraceptives ◽  
Low Dose ◽  
Oral Contraception ◽  
Combined Oral Contraceptives ◽  
Mineral Supplements ◽  
Common Causes ◽  
Natural Hormones

The frequency and severity of side effects induced by the use of combined oral contraceptives (COCs) are the most common causes of withdrawal (64.4%). Better adherence can be achieved through adequate counselling on the choice of contraception and use of extended-regimen low-dose COCs with estrogen component and natural hormones containing novel selective progestins (dienogest, drospirenone) with minimum side effects. The choice of vitamin and mineral supplements based on the relevant micronutrient disbalance in women using COCs and "quick starting" could also contribute to compliance with the chosen method of oral contraception.

Combined oral contraceptives with natural estrogen and sexual function: the optimal method of contraception for women of different ages

GYNECOLOGY ◽  
2019 ◽  
Vol 21 (1) ◽  
pp. 33-37
Author(s):  
Svetlana V Yureneva ◽  
Liliia M Ilina
Keyword(s):  
Quality Of Life ◽  
Beneficial Effect ◽  
Sexual Function ◽  
Oral Contraceptives ◽  
Well Being ◽  
Reproductive Period ◽  
Estradiol Valerate ◽  
Optimal Method ◽  
Combined Oral Contraceptives

Background. Combined oral contraceptives (COCs) are the most common method of prevention of unwanted pregnancies in women from the early reproductive period to perimenopause, therefore their impact on quality of life, sexual function and general well-being remains the subject of active discussion. Some studies revealed various manifestations of sexual dysfunction in patients receiving COCs, therefore such questions, as well as the advantages / disadvantages of individual components (their type and dose) of drugs, are of interest to the clinician. Aim. Assess mechanisms of influence of COCs on female sexual function. Materials and methods. In order to write this review domestic and foreign publications were searched in Russian and international search systems (PubMed, elibrary, etc.) for the last 2-15 years. Relevant articles from the peer-reviewed literature were included. Results. Many studies proved a beneficial effect of estradiol valerate (E2V) which is estrogen identical to natural one in a combination with dienogest (DNG) which is 4th generation progestin in a dynamic dosing regimen on quality of life and sexual function. This beneficial effect is achieved due to combined effects of both components of the drug as well as its reception mode. Conclusion. The combination of estradiol valerate (E2V) which is estrogen identical to natural one with dienogest (DNG) which is 4th generation progestin may be the optimal method of contraception for women of any age, including the young, with decreased libido while taking other COCs.

Sign in / Sign up

Export Citation Format

Share Document